Ketorolac Tromethamine Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-04-20 · last update 2026-04-20
Manufacturers: Mylan Pharmaceuticals Inc., a Viatris Company
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/20/2026 Updated 04/20/2026 Discontinued 04/20/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)